No Data
Information on individual stocks.
Rei <4317.T> continues to rise. A buyback limit of 800,000 Stocks (6.0% of the issued Stocks excluding treasury Stocks) and a 400 million yen buyback allocation has been set. The acquisition period is from April 24 to February 28, 2026. Cave <3760.T> rebounded significantly for the first time in four days. A buyback limit of 100,000 Stocks (1.5% of the issued Stocks excluding treasury Stocks) and a 100 million yen buyback allocation has been set. The acquisition period is from April 24 to June 30. Additionally, the Shareholder benefit program has been expanded, which used to provide QUO cards to Shareholders holding over 1,000 Stocks.
Stocks that moved and those that were traded in the front market.
*Nova Ltd <9519> 654 +49, upward revision of performance to reduce profit decline. *Nomura Micro Science <6254> 2360 +170, expected increase in year-end Dividends. *Sumitomo Electric Industries <5802> 2244 +163, riding the trend of rising Autos-related stocks. *Musashi Seimitsu Industry <7220> 2333 +160, funds are also moving toward Datacenter-related due to the rise in Semiconductors stocks. *Osaka Titanium Technologies <5726> 1624 +109, Boeing's increased production plan.
Notable stocks: Recently listed IPO stocks with high growth expectations.
The Mirairo <335A.T> digital disability certificate app is likely to rise rapidly. By digitizing and linking with the My Number portal, this app allows for online verification of disability certificates. Presenting the app screen at Transportation facilities, Leisure establishments, and local government-related facilities enables individuals to receive disability discounts without needing to show a physical disability certificate. There is a growing demand for training due to the revision of the Disability Discrimination Elimination Law, along with the upcoming Osaka-Kansai Expo.
Growth 250 continues to rise, going against the trend of the overall Tokyo market = Emerging Markets, November 11.
The TSE Growth Market 250 Index continued to rise. While the Nikkei Stock Average and the entire Tokyo market experienced a decline, it showed a contrary movement. Timy <215A.T> rose for four consecutive days, and Trial Holdings <141A.T>, QPS Research <5595.T>, and Sun Bio <4592.T> also increased. The recent IPOs of Mirairo <335A.T> and Toyoko <341A.T> also stood out for their gains. The Standard Market TOP 20 fell back. Provided by Wealth.
Stocks with a limit-up or limit-down in the afternoon session.
■Limit up <149A> Shinka <2334> Iore <4584> Kidswell Bio <6846> Chuo Seisakusho ■Limit down <192A> Integrup <335A> Mirairo <338A> ZenmuTech <4882> Perseus Proteomics *Includes temporary limit up/down (indicative prices).
IPO strategy: Four listings scheduled for April before the Golden Week.
The IPO (initial public offering) rush of March has ended. In April, four stocks are scheduled to be listed, with the next IPO being IACE Travel <343A.T> (Standard, Services) on the 7th. <A series of ongoing projects is gaining momentum> In March, Mirairo <335A.T> (Growth, Communications) became the first to establish an initial price after extending trading hours, and ZenmuTech <338A.T> (Growth, Communications), which handles the deployment of the secret distribution solution "ZENMU" series, also made its debut similarly.
